Effects of astemizole on ventricular activation delay and RT intervals in a canine myocardial infarction model

被引:0
作者
Nishimoto, M
Hashimoto, H
Ohmura, T
Ikeda, Y
Watanabe, S
Ohashi, K
Umemura, K
Nakashima, M
机构
[1] HAMAMATSU UNIV SCH MED, DEPT CLIN PHARMACOL, HAMAMATSU, SHIZUOKA 43131, JAPAN
[2] HAMAMATSU UNIV SCH MED, DEPT PHARMACOL, HAMAMATSU, SHIZUOKA 43131, JAPAN
关键词
astemizole; ventricular activation; RT interval; canine myocardial infarction model;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In order to clarify the arrhythmogenic effects of nonsedating antihistamines, we examined the effects of astemizole, a nonsedating antihistamine, on ventricular activation and RT intervals in a canine myocardial infarction model. Myocardial infarction was produced by two-stage ligation of the left anterior descending coronary artery in dogs. Seven days after ligation, bipolar electrodes were sutured on the ventricular surface of the infarcted and normal zones to apply an electrical stimulation or record the ventricular activation. an electrical stimulation with coupling intervals between 300 and 140 ms was applied on the ventricular surface of the normal zone during atrial pacing, and the ventricular activation delay was measured. The effect of astemizole on the RT interval was also determined during atrial pacing, sinus rhythm or after premature stimulation, The ventricular activation delay increased after astemizole at doses of 0.3 to 3 mg/kg in the infarcted and at 3 mg/kg in the normal zones, and the effect of astemizole was greater in the infarcted zone. Astemizole increased the RT interval in the normal zone to a greater extent at a long coupling interval. The increase in the RT interval was greater in the infarcted zone compared with that in the normal zone, In conclusion, astemizole increased the activation delay in the infarcted zone, probably through prolongation of the repolarization time, and its effect on the activation delay may be arrhythmogenic.
引用
收藏
页码:1020 / 1023
页数:4
相关论文
共 28 条
  • [1] REGULATION OF POTASSIUM CHANNELS BY NONSEDATING ANTIHISTAMINES
    BERUL, CI
    MORAD, M
    [J]. CIRCULATION, 1995, 91 (08) : 2220 - 2225
  • [2] BIGGER JT, 1990, ANTIARRHYTHMIC DRUGS, P840
  • [3] RE-ENTRANT VENTRICULAR ARRHYTHMIAS IN LATE MYOCARDIAL-INFARCTION PERIOD .1. CONDUCTION CHARACTERISTICS IN INFARCTION ZONE
    ELSHERIF, N
    SCHERLAG, BJ
    LAZZARA, R
    HOPE, RR
    [J]. CIRCULATION, 1977, 55 (05) : 686 - 702
  • [4] RE-ENTRANT VENTRICULAR ARRHYTHMIAS IN LATE MYOCARDIAL-INFARCTION PERIOD .4. MECHANISM OF ACTION OF LIDOCAINE
    ELSHERIF, N
    SCHERLAG, BJ
    LAZZARA, R
    HOPE, RR
    [J]. CIRCULATION, 1977, 56 (03) : 395 - 402
  • [5] DELAYED DEVELOPMENT OF VENTRICULAR ECTOPIC RHYTHMS FOLLOWING EXPERIMENTAL CORONARY OCCLUSION
    HARRIS, AS
    [J]. CIRCULATION, 1950, 1 (06) : 1318 - 1328
  • [6] ANTIHISTAMINE ACTIVITY, CENTRAL-NERVOUS-SYSTEM AND CARDIOVASCULAR PROFILES OF HISTAMINE H-1 ANTAGONISTS - COMPARATIVE-STUDIES WITH LORATADINE, TERFENADINE AND SEDATING ANTIHISTAMINES IN GUINEA-PIGS
    HEY, JA
    DELPRADO, M
    CUSS, FM
    EGAN, RW
    SHERWOOD, J
    LIN, CC
    KREUTNER, W
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 1995, 25 (10) : 974 - 984
  • [7] Hey JA, 1996, ARZNEIMITTEL-FORSCH, V46, P153
  • [8] CHANGES IN THE PHARMACOKINETICS AND ELECTROCARDIOGRAPHIC PHARMACODYNAMICS OF TERFENADINE WITH CONCOMITANT ADMINISTRATION OF ERYTHROMYCIN
    HONIG, PK
    WOOSLEY, RL
    ZAMANI, K
    CONNER, DP
    CANTILENA, LR
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (03) : 231 - 238
  • [9] TERFENADINE-KETOCONAZOLE INTERACTION - PHARMACOKINETIC AND ELECTROCARDIOGRAPHIC CONSEQUENCES
    HONIG, PK
    WORTHAM, DC
    ZAMANI, K
    CONNER, DP
    MULLIN, JC
    CANTILENA, LR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (12): : 1513 - 1518
  • [10] TORSADES-DE-POINTES ASSOCIATED WITH TERFENADINE IN A CASE OF LIVER-CIRRHOSIS AND HEPATOCELLULAR-CARCINOMA
    KAMISAKO, T
    ADACHI, Y
    NAKAGAWA, H
    YAMAMOTO, T
    [J]. INTERNAL MEDICINE, 1995, 34 (02) : 92 - 95